The Central Virus Core (CVC) will play a pivotal role in the Birmingham CFAR. The CVC will provide a centralized, fully- equipped, and highly supervised Biosafety Level 3 (BSL 3) laboratory facility for all infectious HIV work by center members and will further serve as a Center resource for the maintenance and storage of thoroughly characterized stocks of HIV virus isolates, infected cell lines, and virus-specific monoclonal and polyclonal antibodies. Although all recombinant HIV plasmid and phage constructs will be catalogued, propagated, and provided to CFAR members through the Molecular Biology Core, the CVC will play an important role in the initial construction of these recombinant HIV containing vectors which are often derived initially from primary or passaged cultures of HIV virus. The CVC directors (Drs. Shaw and Hahn) have demonstrated the successful application of the concept of a CVC for provision of virus-specific reagents by their current ongoing contract with the National Institutes of Allergy and Infectious Diseases for the provision of HIV proviral clones, growing stocks, and relevant genetic information for the NIAID AIDS Reagent Program (Appendix). The six programmatic areas comprising the CFAR Basic Sciences Program and the three programmatic areas comprising the Clinical Sciences Program will maximally utilize the CVC as the primary site for all infectious HIV work, as a source for HIV related reagents, and as a resource for information and experimental design and development relevant to their programmatic areas. Thirty-three NIH funded CFAR members have been identified who will utilize the CVC services. The CVC facility will be centrally located to these investigators and will consist of a 2,000 sq.ft. containment facility having six individual culture rooms, a common shared equipment area containing centrifuges, automated cell counter, microscopes, freezers, and all other equipment required for virus culture and analysis. The CVC will be operated on an at-cost reimbursement basis from the research funds of its users. The CVC will limit potential exposure to infectious HIV to a single tightly controlled laboratory facility providing maximal safety and efficiency, obviate duplication of equipment, and make available to all CFAR members full facilities for HIV research and a complete spectrum of fully characterized, high quality HIV related reagents.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
5P30AI027767-03
Application #
3810412
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
1990
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Rice, Whitney S; Logie, Carmen H; Napoles, Tessa M et al. (2018) Perceptions of intersectional stigma among diverse women living with HIV in the United States. Soc Sci Med 208:9-17
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Fredericksen, R J; Gibbons, L; Brown, S et al. (2018) Medication understanding among patients living with multiple chronic conditions: Implications for patient-reported measures of adherence. Res Social Adm Pharm 14:540-544
Stoll, Matthew L; Weiss, Pamela F; Weiss, Jennifer E et al. (2018) Age and fecal microbial strain-specific differences in patients with spondyloarthritis. Arthritis Res Ther 20:14
Subramaniam, Akila; Van Der Pol, William J; Ptacek, Travis et al. (2018) Midtrimester microbial DNA variations in maternal serum of women who experience spontaneous preterm birth. J Matern Fetal Neonatal Med :1-9
Kay, Emma S; Rice, Whitney S; Crockett, Kaylee B et al. (2018) Experienced HIV-Related Stigma in Health Care and Community Settings: Mediated Associations With Psychosocial and Health Outcomes. J Acquir Immune Defic Syndr 77:257-263
Xu, Wanli; Luo, Zhenwu; Alekseyenko, Alexander V et al. (2018) Distinct systemic microbiome and microbial translocation are associated with plasma level of anti-CD4 autoantibody in HIV infection. Sci Rep 8:12863
Smith, Samuel R; Schaaf, Kaitlyn; Rajabalee, Nusrah et al. (2018) The phosphatase PPM1A controls monocyte-to-macrophage differentiation. Sci Rep 8:902
Wang, Yong; Schafer, Cara C; Hough, Kenneth P et al. (2018) Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol 201:278-295
Jones, Robert B; Dorsett, Kaitlyn A; Hjelmeland, Anita B et al. (2018) The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1? signaling. J Biol Chem 293:5659-5667

Showing the most recent 10 out of 955 publications